Epidemiological studies show that 19.6% to 64.7% of CMT patients carry the PMP22 duplication[22,25], which gives calculated prevalences of CMT1A in the range of 1:3,800 to 1:12,500. This evidence concerns the gene PMP22 and Charcot-Marie-Tooth disease type 1A.